产品详情
Targets
Target | Value |
---|---|
VEGFR2 | IC50: 6.5nM |
VEGFR3 | IC50: 15nM |
EphB2 | IC50: 24nM |
VEGFR1 | IC50: 30nM |
PDGFRα | IC50: 40nM |
PDGFRβ | IC50: 49nM |
c-Kit | IC50: 78nM |
Tie-2 | IC50: 78nM |
EphB4 | IC50: 480nM |
FGFR1 | IC50: 530nM |
c-Met | IC50: 550nM |
Abl | IC50: 620nM |
Src | IC50: 960nM |
FGFR3 | IC50: >1μM |
FGFR4 | IC50: >1μM |
FLT3 | IC50: >1μM |
EGFR | IC50: >1μM |
ErbB2 | IC50: >1μM |
Insulin Receptor | IC50: >1μM |
FAK | IC50: >1μM |
ErbB4 | IC50: >1μM |
IGF-1R | IC50: >1μM |
JAK2 | IC50: >1μM |
In vitro (25°C) | DMSO | 19 mg/mL (41.76 mM) | |
Water | Insoluble | ||
Ethanol | Insoluble | ||
In vivo | 2% DMSO+30% PEG 300+ddH2O | 1 mg/mL | |
* <1 mg/ml means slightly soluble or insoluble. * Please note that Adooq tests the solubility of all compounds in-house, and the actual solubility may differ slightly from published values. This is normal and is due to slight batch-to-batch variations. |
Concentration / Solvent Volume / Mass | 1 mg | 5 mg | 10 mg |
---|---|---|---|
0.1 mM | 21.98 mL | 109.91 mL | 219.83 mL |
0.5 mM | 4.4 mL | 21.98 mL | 43.97 mL |
1 mM | 2.2 mL | 10.99 mL | 21.98 mL |
5 mM | 0.44 mL | 2.2 mL | 4.4 mL |
*The above data is based on the productmolecular weight 454.9 . Batch specific molecular weights may vary from batch to batch due to solvent of hydration, which will affect the solvent volumes required to prepare stock solutions.
目录号 | A10101 |
---|---|
作用机制 | Inhibitor (抑制剂) |
M. Wt | 454.9 |
Formula | C22H19ClN4O5 |
Purity | >99% |
Storage | Store lyophilized at -20ºC, keep desiccated. |
CAS No. | 475108-18-0 |
Synonyms | AV-951, AV951 |
SMILES | CC1=CC(=NO1)NC(=O)NC2=C(C=C(C=C2)OC3=C4C=C(C(=CC4=NC=C3)OC)OC)Cl |
产品标签
Product Questions
Product Questions
Vatalanib (PTK787) 2HCl
Vatalanib (PTK787) 2HCl是一种小分子蛋白激酶抑制剂,可抑制抑制所有已知VEGF受体以及血小板衍生的生长因子…
(-)-Catechin gallate
(-)-Catechin gallate是绿茶的抗氧化成分。在uM浓度下,抑制VEGF诱导的酪氨酸磷酸化。
CYC116 (CYC-116)
CYC116 (CYC-116)是一种有效的Aurora A/B抑制剂,Ki为8.0 nM/9.2 nM,对VEGFR2(Ki为44 nM)作用稍弱。
Cediranib (AZD2171)
Cediranib (AZD2171)是一种高效的VEGFR(KDR)抑制剂,此外对c-Kit和PDGFRβ也具有相似的抑制活性,对VEGFR的选择性比P…
Linifanib (ABT-869)
Linifanib (ABT-869)是一种结构新颖的有效RTK,VEGF和PDGF抑制剂,对人内皮细胞,PDGFR-β,KDR和CSF-1R的IC50分别为0.…
ZM 323881 hydrochloride
ZM 323881 hydrochloride是一种有效且选择性的人血管内皮生长因子受体2(VEGFR2/KDR)激酶活性抑制剂。
BMS-817378
BMS-817378是Met/VEGFR-2双重抑制剂BMS-794833的新型前药。